Pharma Research
Teijin Pharma Licenses Rheumatoid Arthritis Drug Candidate TCK-276 to UK-Based Elevara Medicines in Global Agreement
Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, announced that has entered into an exclusive ...
October 24, 2025 | News
ACM Biolabs and National Cancer Centre Singapore Report Encouraging Asia-Based Early Clinical Findings for ACM-CpG Nanoparticle Immunotherapy
ACM Biolabs, a clinical-stage biotechnology company developing next-generation nanoparticle-based immunotherapies, announced encouraging early clinica...
October 23, 2025 | News
Thermo Fisher’s PPD Business Launches Carbon Calculator to Drive Sustainable Clinical Research
New tool helps sponsors measure, manage and minimize the environmental impact of research The PPD™ clinical research business of Thermo Fisher Scien...
October 22, 2025 | News
10x Genomics and Anthropic Partner to Bring Conversational AI to Single Cell and Spatial Biology
Collaboration enables researchers to begin exploring 10x single cell tools and datasets conversationally, with spatial applications to follow - making adva...
October 21, 2025 | News
Daiichi Sankyo and AstraZeneca’s DATROWAY Combination Delivers 68.2% Response and 95.5% Disease Control in First-Line Metastatic Urothelial Cancer
A confirmed objective response rate of 68.2% and a disease control rate of 95.5% was observed with Daiichi Sankyo and AstraZeneca’s DATROWAY in c...
October 20, 2025 | News
Jacobio Pharma Partners with Oceanpine Capital in RMB 200 Million Equity Deal for Cardiovascular Research Subsidiary
Jacobio Pharma announced that its subsidiary, Beijing Jacobio Pharmaceuticals Co., Ltd. ("Beijing Jacobio"), has entered into a Capital Increase and Equity...
October 16, 2025 | News
SK Bioscience Files Clinical Trial Application in Australia for GBP511 Universal Coronavirus Vaccine
Candidate designed to protect against COVID-19 variants and broader Sarbecoviruses Phase 1/2 study to enroll ~500 healthy adults, with topline results e...
October 16, 2025 | News
Asia University and NucleicAI Forge Alliance to Build Taiwan’s First Sovereign AI Life Science Data Platform
Asia University will partner with NucleicAI LLC, a next-generation platform and data company specializing in AI-driven genomics, precision m...
October 15, 2025 | News
Henlius’ HANSIZHUANG Meets Primary Endpoint in Phase 3 Gastric Cancer Trial
The phase 3 clinical trial of HANSIZHUANG for perioperative gastric cancer treatment met its EFS primary endpoint, supporting an early New Drug Applicati...
October 13, 2025 | News
Ono Pharma Reports Positive Phase 2 Signals for ONO-2808 in Multiple System Atrophy
Efficacy signals were observed in an interim analysis of a Phase 2 clinical trial for ONO-2808, a S1P5 receptor agonist Phase 2 clinical trial was con...
October 13, 2025 | News
MOLCURE and Boehringer Ingelheim Forge AI-Powered Alliance to Accelerate Antibody Drug Discovery
MOLCURE Inc. announced that it has entered into a multi-year strategic research agreement with Boehringer Ingelheim for the discovery of innovative an...
October 08, 2025 | News
Asia-Pacific Takes the Lead in Global Biopharma Resilience: Cytiva’s 2025 Index Highlights Regional Rise Amid Global Slowdown
The 2025 Global Biopharma Index released by Cytiva, a Danaher company, reveals that while the global biopharma ecosystem has experienced a modest decline i...
October 08, 2025 | Analysis
Wasatch BioLabs Expands Long-Read Sequencing Portfolio with Oxford Nanopore Research Assays
Wasatch BioLabs (WBL), a Renew Biotechnologies subsidiary, and the largest U.S. sequencing service provider dedicated exclusively to long-read se...
October 07, 2025 | News
Australia’s Monash University Launches Boston Hub to Accelerate Global Biotech Partnerships
Top‑50 global university deepens its North America and Europe collaborations to fast‑track drug discovery and health innovation. Monash University, Au...
October 06, 2025 | News
Most Read
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
